Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes. [electronic resource]
- International journal of cancer Jul 1987
- 104-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0020-7136
10.1002/ijc.2910400119 doi
Antineoplastic Agents--therapeutic use Cell Line Cell Survival Colonic Neoplasms--drug therapy Drug Resistance Humans Immunity, Innate Interleukin-2--pharmacology Killer Cells, Natural--drug effects Monocytes--drug effects